Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Reexamination Certificate
2006-06-13
2006-06-13
Kennedy, Sharon (Department: 3767)
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
C604S067000
Reexamination Certificate
active
07060059
ABSTRACT:
A closed loop therapy system for controlling a concentration of a substance, such as blood glucose concentration, in the body of a user. The system and method employ a sensor system that measures a glucose level in the body, a controller that uses the measured glucose levels to generate an output that can be used to automatically or manually control an intradermal insulin infusion system to set a constant or time-varying profile of target blood glucose concentrations in a user, and then infuse an appropriate amount of insulin into the body of the user so as to reach and maintain the target values of the blood glucose concentration.
REFERENCES:
patent: 4475901 (1984-10-01), Kraegen et al.
patent: 4494950 (1985-01-01), Fischell
patent: 4559037 (1985-12-01), Franetzki et al.
patent: 5250023 (1993-10-01), Lee et al.
patent: 5558640 (1996-09-01), Pfeiler et al.
patent: 5569186 (1996-10-01), Lord et al.
patent: 5800420 (1998-09-01), Gross et al.
patent: 5860957 (1999-01-01), Jacobsen et al.
patent: 5879326 (1999-03-01), Godshall et al.
patent: 6219574 (2001-04-01), Cormier et al.
patent: 6230051 (2001-05-01), Cormier et al.
patent: 6441747 (2002-08-01), Khair et al.
patent: 6537264 (2003-03-01), Cormier et al.
patent: 6558351 (2003-05-01), Steil et al.
patent: 6653091 (2003-11-01), Dunn et al.
patent: 6669663 (2003-12-01), Thompson
patent: 6740072 (2004-05-01), Starkweather
patent: 6841389 (2005-01-01), Novikov et al.
patent: 2002/0040208 (2002-04-01), Flaherty et al.
patent: 2002/0095134 (2002-07-01), Pettis et al.
patent: 2003/0060753 (2003-03-01), Starkweather
patent: 2003/0073609 (2003-04-01), Pinkerton
patent: 2003/0130616 (2003-07-01), Steil et al.
patent: 2004/0073160 (2004-04-01), Pinkerton
patent: 2004/0082934 (2004-04-01), Pettis
patent: 1048264 (2000-11-01), None
patent: WO 97/48440 (1997-12-01), None
patent: WO9748440 (1997-12-01), None
patent: WO 00/74753 (2000-12-01), None
patent: WO0074753 (2000-12-01), None
patent: WO 02/02179 (2002-01-01), None
patent: WO0202179 (2002-01-01), None
Kan, Shugen; Onodera, Hisashi; Nagayama, Satoshi; Furutani, Eiko; Araki, Mituhiko; and Imamura, Masayuki. “How to Control Blood Glucose Under Continuous Glucose Challenge”,ASAIO Journal 2003, pp. 237-242.
Kan, Shugen; Onodera, Hisashi; Furutani, Eiko; Aung, Tun; Araki, Mituhiko; Nishimura, Haruo; Maetani, Shunzo and Imamura, Masayuki. “Novel Control System for Blood Glucose Using a Model Predictive Method”ASAIO Journal 2000, pp. 657-662.
Author Unknown “Investigational device mimics a pancreas, brings an artificial pancreas one step closer to reality,” ADA Annual Meeting—San Francisco—Jun. 17, 2002.
Chassin L.J. et al. Closed-loop glucose control with IV glucose sampling and SC insulin infusion:Evaluation by simulation studies, EASD 37th Annual Mtg. Sep. 2001, Glasgow, UK; Abstract 221.
Chassin, L.J. et al., Simulating closed-loop glucose control: Effect of delay in glucose measurement. Diabetes (2002) 51:1606 Suppl. 2.
Clemens, A. H., Feedback Control Dynamics for Glucose Controlled Infusion System Med Prog Technol, (1979) 6: 91-98.
Dowd Je, et al., Glucose-based optimization of CHO-cell perfusion cultures. Biotechnology And Bioengineering (2001) 75 (2): 252-256.
Lehman E., et al., Insulin dosage adjustment in diabetes. Journal of Biomedical Engineering (1992) 14:243-249.
Parker, R. S., et al., A Model-Based Algorithm for Blood Glucose Control in Type I Diabetic Patients, IEEE Transactions on Biomedical Engineering, (1999) 46(2):148-157.
Parker, R. S., et al., The Intravenous Route to Blood Glucose Control, IEEE Engineering in Medicine and Biology, (2001) 65-73.
Parker, R.S., et al., Robust H-infinity Glucose Control in Diabetes Using a Physiological Model, AIChE J. (2000) 46 (12):2537-2549.
Parker, R.S., et al., Model Predictive Control for Infusion Pump Insulin Delivery, Proceedings of the IDEE Engineering in Medicine and Biology 18th Annual International Conference, (1996) paper No. 265, Amsterdam, The Netherlands.
Parker R. et al., Control-relevant modeling in drug delivery. Advances in Drug Delivery Reviews, (2001) 48: 211-228.
Hovorka, R. et al., Diabetes Technology & Therapeutics, Jun. 2004, vol. 6, No. 3, pp. 307-318, (Posted online on Jul. 5, 2004).
Shimoda, S. et al., Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas, Frontiers Med. Bioi. Engng (1997) 8 (3) :197-211.
Sorensen J.T., A Physiologic Model of Glucose Metabolism in Man and its Use to Design and Assess Improved Insulin Therapies for Diabetes, PhD Thesis, M.I.T. (1985).
Parker, R. S., et al., “The Intravenous Route to Blood Glucose Control”, IEEE Engineering and Biology 2001, pp. 65-73.
DeNuzzio John D.
Harvey Noel G.
Keith Steven
Parker Robert S.
Pettis Ronald J.
Becton Dickinson and Company
Fiedler Alan W.
LandOfFree
System and method for initiating and maintaining continuous,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method for initiating and maintaining continuous,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method for initiating and maintaining continuous,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3635996